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Abstract—:The role of potassium channels in nociceptive activity 
was proposed in the past decade. Various type of potassium channel 
has been found to exert different action in propogation of action 
potential in nervous system.  As DMPF-1, a chalcone derivative 
possesses antinociceptive properties. The mechanism of its action has 
been carried out to verify the pathway involved. The present study 
addressed the role of potassium channel in the contribution of the 
antinociceptive action of DMPF-1. The involvement of potassium 
channel was evaluated using acetic acid-induced abdominal writhing 
test.The animals were pretreated with charybdotoxin (large Ca2+ 
activated potassium channel blocker)(0.04mg/kg, i.p) or apamin 
(small Ca2+ activated potassium channel blocker)(0.02mg/kg, i.p.) 15 
minutes before administration of DMPF-1. It was demonstrated that 
the challenge of DMPF-1 treated group with charybdotoxin has 
reversed the antinociceptive activity of this novel chalcone, which 
indicates the possible participation of large Ca2+ activated potassium 
channel in antinociceptive effect cause by DMPF-1 but not through 
small Ca2+ activated potassium channel. 
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I. INTRODUCTION 
CCORDING to International Association for the Study of 
Pain (IASP), an unpleasant sensory and emotional 
Noor Azlina Abu Bakar. Department of Biomedical Sciences, Faculty of 
Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM 
Serdang, Selangor, Malaysia (e-mail:noorazlina.abubakar@yahoo.com ).  
Mohd Roslan Sulaiman,. Department of Biomedical Sciences, Faculty of 
Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM 
Serdang, Selangor, Malaysia (e-mail:mrs@medic.upm.edu.my ). 
Ahmad Akira Omar Farouk. Department of Biomedical Sciences, Faculty 
of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM 
Serdang, Selangor, Malaysia (e-mail:akira@medic.upm.edu.my). 
Nordin Lajis. Scientific Chairs Unit, Taibah University, Al-Jazeera Bldg 
#110, Madinah al-Munawarah, 41311 Saudi Arabia (e-mail: 
nordinlajis@gmail.com) 
Mohd Nadeem Akhtar. University Malaysia Pahang, ebuhraya Tun Razak, 
26300Gambang Kuantan, Pahang Darul Makmur 
 
experience associated with actual or potential tissue damage 
due to chemical or thermal stimulus are the definitive of pain. 
Certainly, pain signaling is a defensive mechanism that alerts 
us to real and impending injury thus avoids further tissue 
damage. Even so, pain often becomes chronic and devastating 
as it outlives its efficacy as a warning system which bother 
health and functional capability of a human[1].Many analgesic 
drugs has been developed to overcome pain sensation but they 
bring to bear the toxicity and side effects such as gastric 
ulcer[2], liver damage, hypersensitivity and CNS effects [3]. 
As a consequence several alternative needs to be discover. 
Chalcone is a chain of heterocyclic compound that appear 
abundantly in edible plants, which act as a precursor that 
important for synthesizing various classes of valued 
flavonoids. Several studies using chalcone and its derivatives 
have identified that they exert an important biological activity. 
They possess antibacterial, anticancer [4], antitumor[5], 
antifungal, anti-inflammatory [6] and antinociceptive 
properties [7] as they are capable to inhibit the synthesis of 
prostaglandins [8]. Because of their pharmacological 
properties, DMPF-1 was synthesized. From our previous 
preliminary study, DMPF-1 exerts an antinociceptive activity 
using chemical and thermal-induced nociception therefore it is 
necessary to figure out the mechanisms involved in this action. 
II. MATERIAL AND METHOD 
 
A. Preparation of Compound 
 
The chalcone derivative was obtained from Institute of 
Bioscience, Universiti Putra Malaysia and synthesized by 
Claisen-Schmidt condensation reaction. The compound was 
purified by column chromatography using silica gel mesh size 
(100–200 mesh, Merck) and elution with petroleum ether and 
ethyl acetate. 
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B. Animals 
 
Male ICR albino mice aged 4-6 week old weighed about 20-
25g being used throughout the experiments with free access to 
food and water ad libitum. The animals were housed in room 
with standard constant temperature 24 ± 1oC in 12:12 hours 
dark light cycle.The rules of the ethical guidelines to assess the 
pain in conscious animals[9] was pursued after the approval by 
Animal Care and Use Committee, Universiti Putra Malaysia, 
Serdang, Selangor. Least number of animals (n=10) and 
stimulus (chemical) was employed as it can present the effect 
of the compound. The experimental animals were sacrificed 
once it was used throughout the study.  
 
C. Drugs and chemical used 
 
The subsequent drugs and chemical were used in 
commencing this study: glacial acetic acid (Scharlauchemie 
S.A.), charybdotoxin and apamin (Sigma Aldrich chemical, 
U.S.A). Normal saline was used in order to dissolve all the 
chemicals (0.9% NaCl). DMPF-1 was prepared using vehicle 
that made up of absolute ethanol, Tween 20 (Sigma, Aldrich) 
and distilled water in 5:5:90 (v/v) fractions respectively. The 
dose of treatment used was chosen based on our pilot 
experiment and the volume administered was 10 ml/kg; i.p.  
 
D. Experimental protocol 
 
The participation of potassium channel study was carried 
out using the method described previously with slide 
modification [10]. The groups of mice were pretreated 
intraperitoneally with 0.04mg/kg of charybdotoxin (large Ca2+ 
activated potassium channel blocker) and 0.02mg/kg of 
apamin (small Ca2+ activated potassium channel blocker) 15 
minutes before received DMPF-1 at dose of 1mg/kg, i.p. or 
vehicle 10ml/kg, i.p. Acetic acid 0.6% was intraperitoneally-
injected post 30 minutes of DMPF-1 treatment. The 
nociceptive response was characterized by the cumulative 
number of abdominal writhing from 5 to 30 minutes post 
injection of 0.6% acetic acid, i.p. The reduction in number of 
writhing episode indicated the antinociceptive action of the 
compound.  
 
E.  Statistical analysis 
 
The result was accessible as the mean ± SEM involving 10 
animals per group. The statistical significance comparison 
between groups was evaluated using one-way analysis of 
variance (ANOVA) with Dunnett’s post-hoc test. All 
procedures were carried out using Prism 4.0 software 
(GraphPad Software, San Diego, CA, USA); p<0.05 was 
considered significant 
 
III. RESULTS 
The result in Fig. 1, shows that treatment of charybdotoxin 
at dose of 0.04mg/kg, i.p. alone does not altered the number of 
abdominal writhing induced by 0.6%, i.p injection of acetic 
acid. However it is, as the treatment group of DMPF-1 was 
challenge with this blocker, it reversed the antinociceptive 
activity of this compound. 
In Fig. 2, pretreatment of the animals with apamin at dose of 
0.02mg/kg, i.p. does not altered the antinociceptive effect of 
DMPF-1 compound in acetic acid induced abdominal writhing 
test induced by i.p. injection of acetic acid 0.6% concentration. 
There are significant different as compared to apamin alone 
treated group.  
 
 
 
 
 
Fig.1. Effect of charybdotoxin (0.04mg/kg) on antinociception 
caused by DMPF-1 (1mg/kg) compound in acetic acid-induced 
abdominal writhing test. Each column represents mean ± S.E.M of 10 
mice. ### Denotes significant difference at p<0.001 as compared to 
DMPF-1 treated group. 
 
 
Fig. 2. Effect of apamin (0.02mg/kg) on antinociception caused by 
DMPF-1 (1mg/kg) compound in acetic acid-induced abdominal 
writhing test. Each column represents mean ± S.E.M of 10 mice. ns 
denotes  no significant difference at p<0.001 as compared to DMPF-
1 treated group. 
 
IV. DISCUSSION 
In this present study, the mechanism behind the action of 
this novel chalcone derivatives has been revealed using acetic 
acid induced abdominal writhing test in order to evaluate the 
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involvement of potassium channel in DMPF-1 induce 
antinociception.  Acetic acid induced abdominal writhing 
technique was chosen in this test as it is very sensitive and 
useful to find the analgesic mechanism of compound. 
Nociception activity was triggered with the induction 0.6% 
acetic acid into the peritoneal cavity hint to the released of 
several chemicals mediator such as prostaglandin, increasing 
the cycloxygenase (cox) and lypoxygenase(lox) enzyme[11]. 
All of these mediators caused an irritation to peritoneal region 
thus and episode of abdominal writhing [12] 
Potassium channels were found responsible in neuronal 
excitability[13]. They are several type of potassium channel 
available with different structure and function.Upon activation 
by the agonist, the potassium channel will open and thus 
permits the efflux of potassium ions from nerve cell later cause 
repolarization and/or hyperpolarization that decrease the 
induction of action potential[14]. Because of that capability, 
they become the therapeutic target in finding analgesic drugs. 
Various venom and toxin were establish to obstruct the 
function of potassium channels [15]. Development of selective 
large and small Ca2+ activated potassium channel blocker from 
venom and toxin has provided the pharmacological tool in 
finding the contribution of this channel in pain study.  
As illustrated in fig. 1 and 2, Pretreatment of charybdotoxin 
and apamin alone does not modify the number of abdominal 
writhing in mice. The challenge of DMPF-1 with 
charybdotoxin; a large Ca2+ activated potassium channel 
blocker has reversed the effect of DMPF-1 which mean the 
possible involvement of this channel in antinociceptive action 
of this novel chalcone derivative.  
V. CONCLUSION 
In all, the antinociceptive properties of DMPF-1 was due to 
their potential in opening the large Ca2+ activated potassium 
channel thus reduced the excitability of the neuron and release 
pain sensation. These finding provide a value in DMPF-1 
mechanism of action. 
 
ACKNOWLEDGMENT 
 
The author are grateful to the staff of physiology laboratory 
and animal house, Faculty of Medicine and Health Sciences, 
University Putra Malaysia for providing the financial support 
and necessities for this study. 
 
REFERENCES 
 
[1]. Julius, D. and A.I. Basbaum, Molecular mechanisms of 
nociception.Nature, 2001.413(6852): p. 203-10. 
[2]. Wallace, J.L., Nonsteroidal anti-inflammatory drugs and the 
gastrointestinal tract. Mechanisms of protection and healing: current 
knowledge and future research. Am J Med, 2001. 110(1A): p. 19S-
23S. 
[3]. Merskey, H., Pain and dissociation.Pain, 1993.55(3): p. 281-2. 
[4]. Modzelewska, A., et al., Anticancer activities of novel chalcone and 
bis-chalcone derivatives.Bioorg Med Chem, 2006.14(10): p. 3491-5. 
[5]. Kim, T.H., et al., Anti-tumor effects by a synthetic chalcone compound 
is mediated by c-Myc-mediated reactive oxygen species 
production.ChemBiol Interact.188(1): p. 111-8. 
[6]. Boumendjel, A., et al., A novel chalcone derivative which acts as a 
microtubule depolymerising agent and an inhibitor of P-gp and BCRP 
in in-vitro and in-vivo glioblastoma models. BMC Cancer, 2009. 9(1): 
p. 242. 
[7]. Mohamad, A.S., et al., Antinociceptive activity of a synthetic chalcone, 
flavokawin B on chemical and thermal models of nociception in 
mice.Eur J Pharmacol.647(1-3): p. 103-9. 
[8]. de Campos-Buzzi, F., et al., 4'-Acetamidochalcone derivatives as 
potential antinociceptive agents.Molecules, 2007.12(4): p. 896-906. 
[9]. Zimmermann, M., Ethical guidelines for investigations of experimental 
pain in conscious animals.Pain, 1983.16(2): p. 109-10. 
[10]. Khalid, M.H., et al., Antinociceptive effect of the essential oil of 
Zingiberzerumbet in mice: possible mechanisms. J Ethnopharmacol. 
137(1): p. 345-51. 
[11]. Deraedt, R., et al., Release of prostaglandins E and F in an algogenic 
reaction and its inhibition.Eur J Pharmacol, 1980.61(1): p. 17-24. 
[12]. Sulaiman, M.R., et al., Antinociceptive and anti-inflammatory effects 
of the ethanol extract of AlpiniaconchigeraGriff. leaves in various 
animal models. Methods Find Exp ClinPharmacol, 2009. 31(4): p. 241-
7. 
[13]. Rasband, M.N., et al., Distinct potassium channels on pain-sensing 
neurons. Proc NatlAcadSci U S A, 2001. 98(23): p. 13373-8. 
[14]. Longman, S.D. and T.C. Hamilton, Potassium channel activator drugs: 
mechanism of action, pharmacological properties, and therapeutic 
potential.Med Res Rev, 1992.12(2): p. 73-148. 
[15]. Hugues, M., et al., Apamin as a selective blocker of the calcium-
dependent potassium channel in neuroblastoma cells: voltage-clamp 
and biochemical characterization of the toxin receptor. Proc 
NatlAcadSci U S A, 1982. 79(4): p. 1308-12. 
 
 
 
3rd International Conference on Medical, Biological and Pharmaceutical Sciences (ICMBPS'2013) January 4-5, 2013 Bali (Indonesia)
206
